Insulin × all-cause mortality

Observational studyCritical care (London, England)2016

Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients.

Lonneke A van Vught et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 1,104 people · 2016

Range includes no effect

No clear effect on deaths

−25%−52% to +15%

Bigger than 7 in 10 for all-cause mortality

As reported

HR 0.75, 95% CI 0.48–1.15 · the paper's word: All-cause mortality

Range includes no effect

No clear effect on deaths

+10%−28% to +69%

Bigger than 3 in 10 for all-cause mortality

As reported

HR 1.10, 95% CI 0.72–1.69 · the paper's word: All-cause mortality

Two numbers in the abstract

the abstract, start to end

age, gender and renal insufficiency (HR 0.75, 95 % CI 0.48, 1.15) nor when

malignancy and renal insufficiency (HR 1.10, 95 % CI 0.72, 1.69) nor when

← favours treatmentfavours comparator →
could be chance
All-cause mortality
HR 0.750.48–1.15
All-cause mortality
HR 1.100.72–1.69
MetforminInsulinAll-cause mortality
1 / 3

39 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27495247